GC1118 in Recurrent Glioblastoma Patients With High EGFR Amplification

NCT03618667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma, Adult
EGFR Amplification

Interventions

DRUG: GC1118

Sponsor

Samsung Medical Center